Phenotype Identification Will Open Door to Precision Medicine
Researchers have developed a low-cost, AI-driven method using label-free optical microscopy to identify cancer phenotypes.
Researchers have developed a low-cost, AI-driven method using label-free optical microscopy to identify cancer phenotypes.
New research from a team of scientists — and two specially trained dogs — have scientifically validated man’s best friend can “sniff out” prostate cancer.
A new clinically-validated saliva test has been shown to detect HPV-associated head and neck cancer with high accuracy.
Diatron has launched the P780, a high-performance, cost-efficient clinical chemistry analyzer designed for medium to large laboratories.
A new diagnostic classification module for AHEAD Medicine's Cyto-Copilot platform enhances AML versus non-neoplastic classification.
Researchers have developed a blood-based proteomics model that accurately predicts disease progression in ADPKD.
A real-world study at Our Lady of the Lake Regional Medical Center found Cytovale's IntelliSep test significantly reduced sepsis mortality.
Natera has received two new FDA Breakthrough Device Designations for its personalized Signatera ctDNA test.
Labcorp and NOWDiagnostics have partnered to distribute free First to Know Syphilis Test kits to public health organizations nationwide.